U.S., Aug. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07105098) titled 'NBI-1117568-SCZ3030: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia' on July 29.
Brief Summary: The primary objective for this study is to evaluate the efficacy of NBI-1117568 compared with placebo on improving behavioral and psychological symptoms of schizophrenia in adults.
Study Start Date: Aug., 2025
Study Type: INTERVENTIONAL
Condition:
Schizophrenia
Intervention:
DRUG: NBI-1117568
NBI-1117568 will be administered per schedule specified in the arm description.
DRUG: Placebo
Placebo will be administered per schedule specified in the arm description.
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Neur...